Allergan to hold special stockholders meeting Dec. 18 without restriction

Allergan announced it has reached an agreement with Pershing Square Capital Management and Valeant Pharmaceuticals to hold a special meeting of stockholders on the originally proposed date of Dec. 18 without restriction, according to a press release from Allergan.Additionally, under the terms of the agreement, Pershing Square and Valeant will dismiss their pending litigation in the Delaware Court of Chancery.